Log In | Register
On Tuesday September 15, 2009 the Food and Drug administration approved four new H1N1 vaccines in its attempt to begin vaccinating over 160 million people in October. FDA licensure means that the government has certified the vaccines are made properly and meets specific manufacturing and quality standards. In reality certification of these vaccines is premature as H1N1 vaccine testing just started in August with results pending.
Vaccines approved by the FDA are manufactured and/or distributed by CSL limited, Novartis, sanofi Pasteur, and Medimmune's nasal-spray…. leaving Baxter's CELVAPAN, a mock up A(H1N1) pandemic vaccine using Vero cell technology and Novavax's VLP's recombinant virus particle technology out in the cold. But don't worry about Baxter. Since contracting with The World Health Organization (WHO) and other agencies, Baxter has obtained a reserved seat at the pandemic vaccine supply group meetings and received European Medicines Agency (EMEA) approval and licensure for their vaccine.
sanofi Pastuer
Sanofi Pasteur's monovalent non-adjuvanted vaccine has been proven ineffective with one vaccination. (The New England Journal Of Medicine; 2009) Sanofi's vaccine may not protect you from H1N1 but your chances of developing side effects will be much lower. Sanofi was quick to submit their supplemental application for FDA approval and licensing on August 7, 2009 (one day after they started trials on their H1N1 vaccine) and the FDA acted swiftly to approve it, even after preliminary studies show the vaccine requires two shots to be efficacious. FDAs approval of sanofi Pasture's vaccine proves the dedication of the Department of Health and Human Service (HHS) who promised to purchase and guarantee distribution and consumption of vaccines manufactured by pharmaceutical companies that currently produce seasonal vaccines for the U.S, government.
Novartis
If you receive the Novartis vaccine you will be injected with MF59, the adjuvant comprised of squalene. Squalene has been used (secretly without approval or licensure) in seasonal influenza for twelve years. Studies show that MF59 can cause autoimmunity and has been linked to: arthritis, fibromyalgia, lymphadenopathy, photosensitive rashes, chronic fatigue, chronic headaches, ulcers, dizziness, weakness, memory loss, seizures, mood changes, neuro-psychiatric problems, multiple sclerosis, lupus, and other diseases including autism, alzheimers, and "GULF WAR SYNDROME". Animal rat studies using oil-based adjuvants have demonstrated severe reactions to them, including paralysis, crippling, auto-immune disorders, and severe arthritis, and immune system impact.
Rima Laibow, MD, the Natural Solutions Foundation's Medical Director emphasized the seriousness of the dangers from the H1N1 vaccines containing squalene:
"Never before has squalene been approved for use in a drug in the United States. But once before, when it was allowed in certain military vaccines, more than 60,000 soldiers were hospitalized because of being injected with it in a condition widely known as "Gulf War Syndrome". A Federal Court, in 2004, forbade its involuntary use by United States troops (Doe v Rumsfeld, Civil Action No. 03-707 USDC for District of Columbia).
"This new vaccine has, literally, 1,000,000 times more squalene than that experimental military vaccine, known as "Vaccine A" had. The attempt to rush this dangerous vaccine into the bodies of the public without safety testing is a violation of US law, regulation and medial ethics and must be condemned."
CSL Limited
CSL's H1N1 vaccine is actually supplied by GlaxoSmithKline (GSK). H1N1 vaccines marketed by CSL Limited will include GSK's proprietary adjuvant system ASO3. So what exactly is this new high potency adjuvant? It is another squalene emulsion derived from lipid A molecules found in Gram-negative bacteria, extracted from bacterial cell walls. It is known to be one of the most potent regulators of the immune response, used by the body to alert itself to bacterial infections.
This news should put everyone on high alert because GSK's proprietary adjuvant contains alum and MPL. MPL stands for monophosphoryl lipid A. The adjuvant developed prior to the Gulf war was used in second generation antrhrax vaccines After the war, Army scientists considered MPL to be too toxic after more than two dozen animal studies generated data demonstrating squalene's ability to induce autoimmunity; and evidence that nanodoses of squalene in anthrax vaccine sickened countless military personnel who received squalene-tainted vaccine during AVIP.
If ASO3 is immunogenic, it raises the possibility of a dangerous "cross reaction. The human body is full of lipids and antibodies and immune cells responding to squalene might also respond to other lipids in the body, thus breaking tolerance for endogenous lipids (those native to the human body) and initiating autoimmunity.
Medimmune's Nasal-Spray
AstraZeneca's MedImmune H1N1 nasal-spray technology uses a live attenuated vaccine, which contains weakened forms of a live virus. On July 27, the distinguished British geneticist and biophysicist Dr. Mae-Wan Ho and biologist Prof. Joe Cummins stated that "Vaccines can be dangerous, especially live, attenuated viral vaccines or the new recombinant nucleic acid vaccines, they have the potential to generate virulent viruses by recombination and the recombinant nucleic acids could cause autoimmune diseases. "
A problem with this approach is that in the very young, the nutritionally deficient and the aged, are at risk of immune system paralysis. This can negatively affect the developing brain and lead to language problems, behavioral dysfunction and even dementia. This is especially prevalent in those with nutritional deficiency.
Live vaccines might help extend supplies in any potential shortage and incite a stronger immune response, especially in children with no immunity to the virus. Adults would experience less protection due to less immune system replication of the antibody;" But with a totally new strain, like a pandemic, the idea is maybe everybody would be like children".(J. Treanor; University of Rochester Medical Center)
Conclusion
It appears that we are all being used as experimental lab rats. Millions of people will be vaccinated without any safety data or long-term studies. There is no concern about harming or killing anyone, because the companies (GlaxoSmithKline, Baxter, and Novartis, and others) have been indemnified by the government, so that there is absolutely no recourse for any deaths or injuries these vaccines may cause.
There has been a tremendous rush (called "fast-tracked") to get these vaccines on the market. The tests they have done were only a few days to a few weeks long. This is totally insufficient time to determine any realistic, long-term, and potentially hazardous immune responses. So it is important that you become educated and take responsibility to protect yourself from both H1N1 and an unethical and corrupt system that is ignoring the Precautionary Principle (first do no harm).
No Advertising or Endorsement Implied; No Gratuities Received; For Informational Purposes Only. 'Earnings' distributed by Newsvine Inc. are paid for continued Site use, not in consideration for submission of User Content.
